INTRODUCTION
Glycation, also known as non-enzymic glycosylation, is the condensation reaction between carbohydrate and protein amino groups. The reaction of glucose with amino groups of proteins -results in the formation of a stable oxoamine glucose adduct (Amadori product) through the rearrangement of an aldimine Schiff base [1] [2] [3] . The reactive amino groups can be either the a-NH2 group of the protein N-terminus or e-NH2 groups of certain lysine residues, depending on their accessibility and environment [4] [5] [6] . Glycation has been found to occur both in vivo and in vitro [7] . This reaction is responsible for the formation of the glycosylated (or glycated) haemoglobins and is the cause of the peculiar chromatographic behaviour of haemoglobin A1, [4] . The extent of haemoglobin Al. accumulation depends on the concentration of glucose in the plasma during the preceding weeks (up to 17 weeks, the lifetime of the human erythrocyte). This property has been used successfully as an index of diabetic control [8] . In addition to haemoglobin, other long-lived proteins have been found to undergo glycation in vivo, such as lens crystallins [9] , collagen [10] , low-density lipoprotein [11] , albumin [5] , fibronectin [12] , erythrocyte membrane proteins [13] , bone osteocalcin [6] , and myelin [14] .
Glycation can markedly affect protein function. For example, glycation of the two f-chain N-terminal amino groups that are involved in the binding of 2,3-disphosphoglycerate leads to increased oxygen affinity [15] . Also, glycation of lens crystallin induces a conformational change which increases SH-group exposure to oxidation [16] . In addition, the extent of glycation of functional lysine residues of ribonuclease A is paralleled by increased inactivation of the enzyme [17] .
The human erythrocyte is enriched in glucose transporters, the proteins that facilitate the translocation of D-glucose across the plasma membrane [18, 19] . The human erythrocyte glucose transporter constitutes a large fraction of a group of polypeptides, Band 4.5, which span an Mr range of 66000 to 45000 on SDS/PAGE [20] . The diffuse nature of Band 4.5 is due to heterogeneous biosynthetic glycation [21, 22] . Endoglycosidase F treatment of Band 4.5 decreases biosynthetic glycation by removal of N-linked oligosaccharide moieties, resulting in a sharper glucose transporter protein band on SDS/PAGE, detected both immunologically [22] , and functionally through photolabelling with cytochalasin B [23] . This agent is a potent inhibitor of carrier-mediated D-glucose transport (K, -10-7 M). Cytochalasin B binds to the inward-facing glucose-binding site since it is a competitive inhibitor of glucose efflux [24] . D-Glucosedisplaceable cytochalasin B binding to erythrocyte membranes has a Kd of 10-7 M and a Bmax of 550 pmol/mg. Furthermore, cytochalasin B binding to the glucose transporter exhibits a oneto-one stoichiometry [20] .
The amino acid sequence of the erythrocyte transporter is highly similar to that derived from a cDNA clone of the human Hep G2 hepatoma glucose transporter [25] . Hydropathy analysis of the transporter amino acid sequence suggests that this protein contains 12 membrane-spanning helices [25] . Of these, helices numbers 7-10 are proposed to be involved in glucose transport across the lipid bilayer [26] .
Given the long life span of human erythrocytes and the lack of protein renewal mechanisms in these cells, erythrocyte proteins 'can undergo significant glycation in vivo. Moreover, a lysine residue appears to be essential for cytochalasin B binding and sugar transport [27, 28] . Hence 
Preparation of erythrocyte membranes
Outdated blood was suspended in 10 vol. of phosphatebuffered saline (150 mM-NaCI/10 mM-sodium phosphate, pH 7.4), followed by centrifugation at 3500 g for 5 min at 4°C and collection of erythrocytes. This procedure was repeated three times. Washed erythrocytes were lysed by mixing with 20 vol. of 5 mM-sodium phosphate, pH 8.0. The erythrocyte membranes were collected by centrifugation at 31 000 g for 15 min at 4 'C. The membranes were washed free of haemoglobin by resuspension and centrifugation at least four more times in 5 mM-sodium phosphate, pH 8.0 [29] .
Purification of Band 4. 5 The method used was essentially that of Baldwin et al. [20] . Erythrocyte membranes (4 mg of protein/ml) were stripped of peripheral proteins by mixing with 15.4 mM-NaOH/2 mm-EDTA/0.2 mM-dithiothreitol (DTT) for 10 min. The membranes were immediately centrifuged at 48000 g for 15 min at 4 'C and the pellets were resuspended in 50 mM-Tris/HCl, pH 6.8. The membranes were centrifuged again and the pellets were resuspended in 50 mM-Tris/HCl/2 mM-DTT, pH 7.4, to a final protein concentration of 2 mg/ml. Solid octyl glucoside was added to a final concentration of 46 mm and the membranes were shaken for 20 min at 4 'C. The membranes were centrifuged at 130000 g for 1 h. A sample of the supernatant (30 ml) was applied to a 2.5 cm x 6.3 cm column of DE-52 equilibrated with 34 mM-octyl glucoside in 50 mM-Tris/HCl/2 mM-DTT, pH 7.4. The column was eluted with the column equilibration buffer at 70 ml/h, and 2 [13] , based on the permanent incorporation of 3H into the Schiff base and oxoamine products of glycation upon reduction with NaB3H4. Briefly, a 100-fold molar excess of NaB3H4 (1400 mCi/mmol) over protein was used, assuming an average Mr of 100000 for membrane proteins. The membranes were concentrated to 7 mg of protein/ml in a Hettich Microfuge at 11000g for 10min at 4°C, NaB3H4 was added to a final concentration of 7 mm and the mixture was incubated for 40 min at room temperature. Unreacted NaB3H4 was washed away by dilution with 10 vol. of 5 mM-sodium phosphate, pH 8.0, followed by two centrifugation steps at 11000 g for 10 min at 4 'C and two centrifugations with 200 vol. at 31000 g for 20 min at 4 'C. NaB3H4 adds a stable radioactive label to the carbon chain of the aldimine and oxoamine glycation products forming hexitollysine derivatives. Since one 3H atom (or H atom) is incorporated per glycation product, the amount of radioactivity incorporated into protein is a measure ofglycation. Radioactivity incorporated specifically into Band 4.5 was determined by endoglycosidase F treatment of membranes followed by SDS/PAGE and gel slicing or by immunoprecipitation with an anti-(Band 4.5) rabbit serum.
Separation of 3H-labelled,-endoglycosidase F-treated, Band 4.5. 3H-labelled membranes (25 or 30 ,g of protein) in 5 mM-sodium Glycation of glucose transporter phosphate, pH 8.0, were taken to dryness in a Speed-vac. The dry residue was resuspended by agitation and sonication in 40 4ul of incubation buffer (250 mM-sodium acetate, 20 mM-EDTA, 10 mM-/J-mercaptoethanol, 0.1 mM-PMSF, 0.01 mM-E-64 and 3.1 mM-NaN3, pH 6.2). Endoglycosidase F (0.5 units, 10 ,ll) was added to each membrane sample, and the tubes were capped and incubated at 37°C with rotation for 18 h. A 50,u1 portion of SDS/PAGE sample buffer (0.25 M-Tris/HCI, pH 6.8, 4 % SDS, 20 % glycerol, 50 mM-DTT and Bromophenol Blue) was then added to each sample, and proteins were separated by SDS/ PAGE and stained with Coomassie Blue. The samples lanes were sliced into 2 mm slices, digested with 0.75 ml of 30 0/o H202 at 60°C for 3 h or more and radioactivity was determined by scintillation counting in 10 ml of scintillation cocktail. Addition of detergents (0.5%o Triton X-100 and 0.05% SDS) to the endoglycosidase F incubation, as described by Lienhard et al. [22] , was omitted, since it did not increase the apparent efficiency of the reaction, and furthermore led to the formation of high molecular aggregates of the glucose transporter as detected by Western blotting (results not shown).
Immunoprecipitation of 3H-labelled Band 4.5. A 100 ,ug portion of 3H-labelled membranes at 2 mg of protein/ml was solubilized with 1 vol. of 50% Nonidet P-40/2 % sodium deoxycholate/ 330 mM-EDTA/50 mm Tris/Cl (pH 7.4)/5 % SDS (buffer A) to 4 vol. of membrane suspension, and PMSF (0.5 mg/ml) and pepstatin (0.02 mg/ml) were added. The samples (60 41) were mixed by rotation for 30 min at 4°C and then diluted 9-fold with 480,ul of 1 % Nonidet P-40/0.40% sodium deoxycholate/66 mm-EDTA/50 mM-Tris/Cl (pH 7.4) (buffer B). Antiserum or preimmune serum (60 ,l) was added to the diluted samples, so that they were diluted 10-fold and the final concentration of SDS was 0.1 % (w/v). The samples were incubated overnight at 4°C and then 150 ,tl of Protein A-Sepharose CL-4B beads, suspended in phosphate-buffered saline + 0.1 % NaN3 at 20 % (v/v), was added (in a 3-fold excess). The amount of Protein A-Sepharose beads used was based on the assumption that 1 ,1 of swollen beads binds 10 ,ug of rabbit IgG, and that serum contains 20 ,ug of IgG/,ul. After incubation for 2 h at room temperature with mixing, the beads were pelleted by a 20 s high-speed spin in a Hettich Microfuge. The supernatants were discarded and the pellets were washed once with 1 ml of buffer B containing 0.5 % SDS and twice with 1 ml of phosphate-buffered saline. After centrifugation, the bottom of each Microfuge tube was cut off into scintillation vials. Scintillation cocktail (10 ml) was added and the samples were counted for 3H radioactivity. Samples containing preimmune serum in place of antiserum were incubated in parallel to measure non-specific immunoprecipitation. The 3H radioactivity measured in the preimmune serum samples was subtracted from the 3H radioactivity measured for parallel antiserum samples. [35] . RESULTS 
Glycation of erythrocyte membranes
Membranes were incubated for 3 days at 37°C with or without 80 mM-D-glucose as described in the Experimental section. After the incubation, the membranes were washed and treated with NaB3H4 to label the glycation sites. The extent of glycation was determined by treating the membranes with endoglycosidase F followed by SDS/PAGE and gel slicing. Fig. 1(a) This region was excised and prepared for scintillation counting as described in the Experimental section. Care was taken not to include the thin distinct band at an Mr of 43000 in the gel slices.
It should be stated that endoglycosidase F cannot remove the NaBH4-reduced hexitol derivative of glucose from proteins. The reason for the difference in 3H-labelling between the unincubated and incubated samples is not totally clear, but it may be due to oxidation of Band 4.5 (which generated NaB3H -reducible sites) during the incubation process. Outdated blood was used throughout this study to provide erythrocyte membranes. These blood samples were stored in the presence of dextrose for several weeks after collection before their use. Band 4.5 isolated from these samples is already glycated before incubation (see Table 1 , expt. B). An experiment was performed to compare the glycation of membranes in these stored samples with that of freshly drawn blood. Membranes prepared from stored and freshly drawn blood were 3H-labelled and proteins were precipitated with trichloroacetic acid. On average, the radioactivity associated with membrane proteins prepared from outdated blood was 1.3-fold higher than the radioactivity associated with membrane proteins from freshly drawn blood (results not shown). However, this difference should not compromise the difference observed in glycation between control and glucose-incubated samples within the same blood sample. Table 1 , expt. B). These calculations were based on (i) an estimate of the number of copies of glucose transporters applied to SDS/PAGE, measured by binding of cytochalasin B in the control membranes (see Fig. 2) ; and (ii) the fact that one cytochalasin B molecule binds per glucose transporter polypeptide [20] . These values demonstrate that, under the conditions used, glycation occurs on approx. 10-20 % of the glucose transporter molecules, for 3 and 6 day incubations at 80 mm-and 200 mM-glucose respectively. The amount of glycation of Band 4.5 was also determined by immunoprecipitation of the glucose transporter from 3H-labelled membranes: control-incubated membranes and glucoseincubated (80 mM-glucose for 3 days) membranes were treated with anti-(Band 4.5) antiserum as described in the Experimental section. The results are presented in Table I (expt. D) and indicate that the membranes glycated in vitro had more glycation than control membranes. In several independent experiments a difference between control and glycated samples was always observed, although significant variation in the amount of 3H incorporated was observed associated with the immunoprecipitate. This raised the possibility that 3H-labelled lipids remaining associated with the Band 4.5 molecules after immunoprecipitation could be the source of the variation. Lipids can react with NaB3H4 at sites of unsaturation (carbon-carbon double bonds) and at oxidized sites that may have resulted from lipid peroxidation. Therefore the amounts of 3H incorporated into membrane protein from two sets of 3-day-control and 3-dayglycated membranes were determined. Delipidation was achieved by acetone precipitation of membrane protein as described in the Experimental section. The results indicated that 40-50 % of the 3H radioactivity was precipitated with the protein pellet, whereas 50-60 % remained in the acetone supernatant and is therefore probably associated with lipid (Table 2) .
When the membranes were immunoprecipitated and analysed by SDS/PAGE, Band 4.5 ran as a broad band, and in addition significant aggregation was noted. Thus it was difficult to account for all of the Band-4.5-associated radioactivity using gel slicing. This precluded the use of SDS/PAGE as a means to first delipidate immunoprecipitated Band 4.5 and then quantify the extent of glycation. In contrast, the diffuse migration of Band 4.5 in SDS/PAGE was not a complication of the endoglycosidase F procedure described in Fig. 1 and Table 1 . Therefore those results are considered to better represent the 3H label associated with Band 4.5. Also, these results are not complicated by 3H incorporation into lipid, since the gel front of endoglycosidase-Ftreated membrane samples separated by SDS/PAGE contained large amounts of 3H radioactivity (results not shown). Presumably this radioactivity is associated with lipid which migrates in this region during SDS/PAGE.
[3HICytochalasin B binding to control and glycated membranes
[3H]Cytochalasin B binding was used to determine whether glycation could affect glucose transporter function. Since cytochalasin B is a highly specific competitive inhibitor and ligand of the glucose transporter, it is a useful tool for probing the integrity of the glucose-binding domain. (Table 3) , the 6-day-glycated sample had a decreased Bmax relative to controls; however, the percentage decrease was 40 %, It is noteworthy that the decrease in cytochalasin B binding exceeds the extent of glycation, in absolute terms, suggesting that this fall may result from a co-operative process between glycated glucose transporters (and/or glycated membrane proteins) and non-glycated glucose transporters, affecting cytochalasin-B-binding properties of non-glycated glucose transporters in the membrane. In addition, the calculation of the percentage glucose transporter glycation may be an underestimate, since the recovery of radioactivity from the endoglycosidase-F-treated samples separated by SDS/PAGE was assumed to be 100 % efficient, but in fact it may not be complete. Further, our calculations assumed that the NaB3H4 was 100% pure. It is known that NaB3H4 decomposes spontaneously in solution (0.01 M-NaOH) to 3H20 or 3H2 gas, so that the value of the specific radioactivity of true NaB3H4 was most probably an overestimate.
In all the incubation experiments in vitro, the control samples were mixed with glucose (80 or 200 mM) just before washing and centrifugation (see the Experimental section) in order to compensate for possible non-specific effects of free glucose that may remain with the glycated membranes after the washing steps. Moreover, the effectiveness of the membrane-washing procedure was tested using cytochalasin B binding assay. Membranes were exposed to 0, 80 [36] . Also, it has been previously shown that all erythrocyte membrane proteins from the blood of diabetic individuals have 2-fold-increased glycation, i.e. no protein shows enhanced increase in glycation compared with another [13] . Glycation of Band 4.5 measured in the present study is probably associated with both transporters since they co-migrate on SDS/ polyacrylamide gels after extensive endoglycosidase F treatment similar to that used in this study [37, 38] ; however, given the prevalence of the glucose transporter in Band 4.5, the majority of the glycation measured is most probably associated with the glucose transporter.
The results in this study indicate that Band 4.5 can be glycated in vitro. In control erythrocyte membranes, approx. 5-6 % of the Band 4.5 was found to be naturally glycated, and this value increased to nearly 11 % on exposure in vitro to 80 mM-D-glucose for 3 days and to 21 % after exposure to 200 mm for 6 days. Glycation of the Band 4.5 was accompanied by a decrease in the specific binding of cytochalasin B. Therefore it is possible that glycation results in the modification of sites in the glucose transporter that are crucial for cytochalasin B binding and possibly for glucose transport. Increases in glycation of other proteins have been observed in diabetic individuals with attendant hyperglycaemia. For example, haemoglobin A,, has a glycated fl-chain N-terminus [1, 33, 39] .
Normal glycaemia results in glycation of 4-6% of the total haemoglobin. Diabetic individuals in poor glycaemic control have haemoglobin Al. glycation values of 100% or more, an increase of 2-fold over normals. Likewise, erythrocyte membrane proteins from diabetic patients have glycation levels some 2-fold above the levels measured in normal individuals [13] . Thus the incubation of normal erythrocyte membranes for 3 days at 80 mM-D-glucose used in this study caused a similar increase in glycation of Band 4.5. to that observed for haemoglobin in diabetic subjects. This glucose concentration and the duration of the incubation are equivalent to the glucose exposure that would occur at 10 mM-glucose for 24 days (this concentration of glucose is not unusual in diabetic individuals).
The results of cytochalasin B binding to membranes glycated in vitro indicated that glycation caused a clear decrease in the maximum binding, with little change in the binding affinity. Since cytochalasin B is thought to bind at the cytoplasmic glucose-binding site [24] , these results may suggest glycation of a cytoplasmically oriented amino group in cytochalasin B binding and possibly in glucose binding. Like glucose, cytochalasin B has electron-accepting functional groups that are predicted to be important in binding to the glucose transporter and which can interact with electron-donating functional groups such as amino groups [40] . Furthermore, reaction of erythrocyte membranes with the NH2-modifying reagent 1-fluoro-2,4-dinitrobenzene inhibits cytochalasin B binding [27] , and the NH2-modifying reagent trinitrobenzenesulphonate inhibits sugar transport in erythrocytes [28] , lending further support to the involvement of an amino group in glucose transporter function.
In conclusion, we have demonstrated that the erythrocyte glucose transporter can be glycated in vitro. Furthermore, glucose transporter glycation is accompanied by a decrease in its ability to bind cytochalasin B. As stated above, this may reflect a change in the binding of glucose to the transporter and an alteration in glucose transporter function; however, more direct approaches will be required to support this hypothesis. Lastly, it will be of great interest to measure the degree of glucose transporter glycation in diabetic individuals in vivo and to determine what effects this may have on glucose uptake.
